Cancer BiologybioRxiv
SHP2 Is Required for BCR-ABL1-Induced Hematologic Neoplasms
S. Gu, A. Sayad, G. Chan…·B. G. Neel
This study shows SHP2 is essential for BCR-ABL1-induced hematologic cancers, affecting proliferation and signaling pathways in pre-B cells.
DOI 10.1038/leu.2017.250